1887
Surveillance and outbreak report Open Access
Like 0

Abstract

Measles re-emerged in a nationwide outbreak in Bulgaria from 2009 to 2011 despite reported high vaccination coverage at national level. This followed an eight-year period since the last indigenous cases of measles were detected. The Bulgarian National Centre of Infectious and Parasitic Diseases collated measles surveillance data for 2009–2011. We analysed data for age group, sex, ethnicity, diagnosis confirmation, vaccination, hospitalisation, disease complications, and death and describe the outbreak control measures taken. The outbreak started in April 2009 following an importation of measles virus and affected 24,364 persons, predominantly Roma. Most cases (73%) were among children < 15 years old. Vaccination status was available for 52% (n = 12,630) of cases. Of children 1–14 years old, 22% (n = 1,769) were unvaccinated and 70% (n = 5,518) had received one dose of a measles-containing vaccine. Twenty-four measles-related deaths were reported. The Roma ethnic group was particularly susceptible to measles. The magnitude of the outbreak resulted primarily from the accumulation of susceptible children over time. This outbreak serves as a reminder that both high vaccination coverage and closing of immunity gaps across all sections of the population are crucial to reach the goal of measles elimination.

Loading

Article metrics loading...

/content/10.2807/1560-7917.ES.2016.21.9.30152
2016-02-03
2017-11-21
http://instance.metastore.ingenta.com/content/10.2807/1560-7917.ES.2016.21.9.30152
Loading
Loading full text...

Full text loading...

/deliver/fulltext/eurosurveillance/21/9/eurosurv-21-30152-4.html?itemId=/content/10.2807/1560-7917.ES.2016.21.9.30152&mimeType=html&fmt=ahah

References

  1. Gacheva N, Kojouharova M, Vladimirova N, Novkirishki V, Kurchativa A, Voynova V, et al. [Acute infectious diseases in Bulgaria in 2001. Analysis of the main epidemiological indicators]. Information Journal NCIPD. 2002;40(5). Bulgarian.
  2. Gatcheva N, Chakov B, Kamenova P, Vladimirova N, Popova ST, Todorova M, et al. [Acute infectious diseases in Bulgaria in 1992. Analysis of main epidemiological indicators]. Information Journal NCIPD. 1993;5-29(5). Bulgarian.
  3. Marinova L, Kojouharova M, Mihneva Z. An ongoing measles outbreak in Bulgaria, 2009. Euro Surveill. 2009;14(26):19259. Available from: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19259 PMID: 19573512 
  4. Marinova L, Muscat M, Mihneva Z, Kojouharova M. An update on an ongoing measles outbreak in Bulgaria, April-November 2009. Euro Surveill. 2009;14(50):19442. Available from: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19442 PMID: 20070938 
  5. World Health Organization (WHO) Regional Office for Europe. Eliminating measles and rubella and prevention congenital rubella infection, WHO European region strategic plan 2005-2010. Copenhagen: WHO. [Accessed 10 Jan 2015]. Available from: http://www.euro.who.int/__data/assets/pdf_file/0008/79028/E87772.pdf
  6. Mihailov A, Mihneva Z. [Specific immunoprophylaxis for measles in Bulgaria]. Information Journal NCIPD. 2004;36-40(6). Bulgarian.
  7. Marinova L, Kojouharova M, Mihneva Z.[Measles Epidemic in Bulgaria in 2009-2010: Reasons and Lessons Learnt]. Pediatria. 2011;1:38-43. Bulgarian. Available from: http://www.spisanie-pediatria-bg.eu/index.php?option=com_content&view=article&id=268&Itemid=892
  8. National Statistical Institute (NSI). Census 2011. Sofia: NSI; 2012. [Accessed 24 Aug 2012]. Available from: www.nsi.bg/census2011/PDOCS2/Census2011final_en.pdf
  9. Verbeff PE. [Measles]. In: Verbeff PE, ed. [Special epidemiology]. Sofia: Medicina & Fiscultura, 1957:237-252. Bulgarian.
  10. Ministry of Health of Bulgaria. [Ordinance 21/18.07.2005 on the procedure for registration, notification and reporting of communicable diseases]. State Gazette. 2005;62. Bulgarian. Available from: http://www.mh.government.bg/Articles.aspx?lang=bg-BG&pageid=391&categoryid=314&articleid=552
  11. Commission decision of 19 March 2002 laying down case definitions for reporting communicable diseases to the Community network under Decision No 2119/98/EC of the European Parliament and of the Council (2002/253/EC), Official Journal of the European Communities 03.04.2002. [Accessed 24 Mar 2015]. Available from: http://eur-lex.europa.eu/legal-content/EN/TXT/?qid=1430041389559&uri=CELEX:32002D0253
  12. World Health Organization (WHO). Manual for the laboratory diagnosis of measles and rubella virus infection. Second edition. Geneva: WHO; 2007. [Accessed 10 Feb 2015]. Available from: http://www.who.int/ihr/elibrary/manual_diagn_lab_mea_rub_en.pdf
  13. Tischer A, Santibanez S, Siedler A, Heider A, Hengel H. Laboratory investigations are indispensable to monitor the progress of measles elimination--results of the German Measles Sentinel 1999-2003. J Clin Virol. 2004;31(3):165-78.  https://doi.org/10.1016/j.jcv.2004.05.007  PMID: 15465408 
  14. World Health Organization (WHO).New genotype of measles virus and update on global distribution of measles genotypes. Wkly Epidemiol Rec. 2005;80(40):347-51. PMID: 16240986 
  15. Thompson JD, Gibson TJ, Plewniak F, Jeanmougin F, Higgins DG. The CLUSTAL_X windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools. Nucleic Acids Res. 1997;25(24):4876-82.  https://doi.org/10.1093/nar/25.24.4876  PMID: 9396791 
  16. Tamura K, Dudley J, Nei M, Kumar S. MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0. Mol Biol Evol. 2007;24(8):1596-9.  https://doi.org/10.1093/molbev/msm092  PMID: 17488738 
  17. World Health Organization (WHO).Measles virus nomenclature update: 2012. Wkly Epidemiol Rec. 2012;87(9):73-81. PMID: 22462199 
  18. Measles Nucleotide Surveillance database. [Accessed 11 Dec 2014]. Available from: www.who-measles.org
  19. National statistical Institute Bulgaria. Population. 2012 [Accessed 15 Nov 2012]. Available from: http://www.nsi.bg/publications/Bulgaria_2012.pdf
  20. Mankertz A, Mulders MN, Shulga S, Kremer JR, Brown KE, Santibanez S, et al. Molecular genotyping and epidemiology of measles virus transmission in the World Health Organization European Region, 2007-2009. J Infect Dis. 2011;204(Suppl 1):S335-42.  https://doi.org/10.1093/infdis/jir101  PMID: 21666182 
  21. Rota PA, Brown K, Mankertz A, Santibanez S, Shulga S, Muller CP, et al. Global distribution of measles genotypes and measles molecular epidemiology. J Infect Dis. 2011;204(Suppl 1):S514-23.  https://doi.org/10.1093/infdis/jir118  PMID: 21666208 
  22. Ministry of Health of Bulgaria. [National programme for elimination of measles and congenital rubella infection (2005-2010).] Sofia: Ministry of Health: 2005. [Bulgarian].
  23. Roma Health Mediators. Successes and Challenges. Open Society Foundations. 2011. New York.
  24. Kaic B, Gjenero-Margan I, Kurecic-Filipovic S, Muscat M. A measles outbreak in Croatia, 2008. Euro Surveill. 2009;14(1):19083. Available from: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19083 PMID: 19161711 
  25. Georgakopoulou T, Grylli C, Kalamara E, Katerelos P, Spala G, Panagiotopoulos T. Current measles outbreak in Greece. Euro Surveill. 2006;11(2):E060223.2. Available from: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=2906 PMID: 16804217 
  26. Curtale F, Perrelli F, Mantovani J, Ciofi degli Atti M, Filia A, Nicoletti L, et al. Description of two measles outbreaks in the Lazio Region, Italy (2006-2007). Importance of pockets of low vaccine coverage in sustaining the infection. BMC Infect Dis. 2010;10(1):62.  https://doi.org/10.1186/1471-2334-10-62  PMID: 20219143 
  27. Rogalska J, Santibanez S, Mankertz A, Makowka A, Szenborn L, Stefanoff P. Spotlight on measles 2010: An epidemiological overview of measles outbreaks in Poland in relation to the measles elimination goal. Euro Surveill. 2010;15(17):19549. Available from: www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19549 PMID: 20460084 
  28. Parmakova K, Kojouharova M, Borisova M, Kurchatova A. [Cross-sectional survey of vaccination coverage with routine immunisations in children born in 2006 in Sofia region]. Bulgarian. Pediatria2010;3(3):23-8.
  29. Andrews N, Tischer A, Siedler A, Pebody RG, Barbara C, Cotter S, et al. Towards elimination: measles susceptibility in Australia and 17 European countries. Bull World Health Organ. 2008;86(3):197-204.  https://doi.org/10.2471/BLT.07.041129  PMID: 18368206 
  30. World Health Organization (WHO).Measles. Progress towards global control and regional elimination, 1998-1999. Wkly Epidemiol Rec. 1999;74(50):429-34. PMID: 10647325 
  31. Unpublished data. National Centre of Infectious and Parasitic Diseases, Sofia, Bulgaria.
  32. Rechel B, Blackburn CM, Spencer NJ, Rechel B. Access to health care for Roma children in Central and Eastern Europe: findings from a qualitative study in Bulgaria. Int J Equity Health. 2009;8(1):24.  https://doi.org/10.1186/1475-9276-8-24  PMID: 19566936 
  33. Rechel B, Spencer N, Blackburn C, Holland R, Rechel B. Impact of health reforms on child health services in Europe: the case of Bulgaria. Eur J Public Health. 2009;19(3):326-30.  https://doi.org/10.1093/eurpub/ckp027  PMID: 19304729 
  34. Strebel PM, Papania MJ, Dayan GH, Halsey NA. Measles vaccine. In: Plotkin SA, Orenstein WA and Offit PA, editors. Vaccines. 5th ed.: St Louis, Saunders; 2008.
  35. Mankertz A, Mihneva Z, Gold H, Baumgarte S, Baillot A, Helble R, et al. Spread of measles virus D4-Hamburg, Europe, 2008-2011. Emerg Infect Dis. 2011;17(8):1396-401.  https://doi.org/10.3201/eid1708.101994  PMID: 21801615 
  36. Lim TA, Marinova L, Kojouharova M, Tsolova S, Semenza JC. Measles outbreak in Bulgaria: poor maternal educational attainment as a risk factor for medical complications. Eur J Public Health. 2013;23(4):663-9.  https://doi.org/10.1093/eurpub/cks182  PMID: 23302763 
  37. Komitova R, Kunchev A, Mihneva Z, Marinova L. Nosocomial transmission of measles among healthcare workers, Bulgaria, 2010. Euro Surveill. 2011;16(15):19842. Available from: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19842 PMID: 21507322 
  38. World Health Organization (WHO) Regional Office for Europe. The Guide to Tailoring Immunisation Programmes (TIP). Copenhagen: WHO. [Accessed 28 Jan 2015]. Available from: http://www.euro.who.int/__data/assets/pdf_file/0003/187347/The-Guide-to-Tailoring-Immunisation-Programmes-TIP.pdf?ua=1
  39. Butler R, MacDonald NESAGE Working Group on Vaccine Hesitancy. Diagnosing the determinants of vaccine hesitancy in specific subgroups: The Guide to Tailoring Immunization Programmes (TIP). Vaccine. 2015;33(34):4176-9.  https://doi.org/10.1016/j.vaccine.2015.04.038  PMID: 25896376 
  40. World Health Organization (WHO). Regional Office for Europe. Tailoring Immunization Programmes. Outputs of pilot implementation in Bulgaria. Copenhagen: WHO. [Accessed 2 Feb 2015]. Available from: http://www.euro.who.int/__data/assets/pdf_file/0011/262010/Tailoring-Immunization-Programmes-TIP-Outputs-of-pilot-implementation-in-Bulgaria.pdf?ua=1
  41. European Centre for Diseases Prevention and Control (ECDC). Let's talk about protection. [Accessed 27 Jan 2014]. Available from: http://ecdc.europa.eu/en/healthtopics/immunisation/comms-aid/Pages/protection.aspx
  42. Marinova L, Parmakova K, Kojouharova M. Striving for better communication with underserved communities in Bulgaria - A step towards improving immunisation coverage. In: Problems of Infectious and Parasitic Diseases. (42), 2. Sofia, National center of infectious and parasitic diseases; 2014. p. 35-8. ISSN 0204-915. [Accessed 27 Mar 2014]. Available from: http://www.ncipd.org/UserFiles/Problems_Pages_2014-2.pdf
  43. World Health Organization (WHO). Regional Committee for Europe. Sixtieth session, 2010. Renewed commitment to elimination of measles and rubella and prevention of congenital rubella syndrome by 2015 and Sustained support for polio-free status in the WHO European Region. Copenhagen: WHO. [Accessed 27 Jan 2014]. Available from: http://www.euro.who.int/__data/assets/pdf_file/0016/122236/RC60_eRes12.pdf
/content/10.2807/1560-7917.ES.2016.21.9.30152
Loading

Data & Media loading...

Comment has been disabled for this content
Submit comment
Close
Comment moderation successfully completed
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error